Hetero Pharmacy

Hetero Pharmacy is a pharmaceutical company focused on developing and manufacturing high-quality medicines. Its operations span various therapeutic areas, ensuring accessibility to essential healthcare solutions. Hetero Pharmacy specializes in the production of generic pharmaceuticals and has its headquarters in Hyderabad, India. Founded in 2007 by Partha Saradhi Reddy, the company has engaged in two significant funding rounds.

Its latest funding round was an Add-on round where they raised INR 1460. 000 mn, led by Apollo Hospitals Enterprise Ltd. , which also participated as an investor. Hetero Pharmacy offers a diverse range of pharmaceutical products, including generic medicines and patented formulations, aimed at addressing various health issues across medical fields.

The company’s offerings are marketed internationally, catering to markets in North America, Europe, and Asia-Pacific. Hetero Pharmacy focuses on delivering affordable healthcare solutions that meet the needs of patients and healthcare providers alike. In the most recent fiscal year of 2023, Hetero Pharmacy reported a revenue of INR 2,971,819 mn, with an EBITDA of INR 2,603,243. 2 mn.

The company’s revenue model includes direct sales and subscription services, fostering long-term relationships with clients across various sectors. Looking ahead, Hetero Pharmacy plans to launch new pharmaceutical products targeting chronic diseases within the next two years. The company aims to expand its presence in key markets, including Europe and North America, by the end of 2025. The recent funding of INR 1460.

000 mn will be allocated towards enhancing their manufacturing capabilities and supporting research and development initiatives. Additionally, the exit of Apollo Hospitals Enterprise Limited from its stake in Hetero Pharmacy indicates strategic shifts for future partnerships.